Mechanisms of mammalian Wnt5a-Ror signaling
哺乳动物 Wnt5a-Ror 信号传导机制
基本信息
- 批准号:10712747
- 负责人:
- 金额:$ 44.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultBindingBiochemistryBiological AssayCarrier ProteinsCell CommunicationCell fusionCell membraneCellsCellular biologyChemicalsClinicalComplexCongenital AbnormalityCryoelectron MicroscopyCysteine-Rich DomainCytoplasmCytoplasmic TailDevelopmentDimerizationDiseaseDrosophila genusDsh proteinDwarfismEndoplasmic ReticulumEventExhibitsExtracellular DomainFaceFamilyG-Protein-Coupled ReceptorsGenitalGenitaliaHomodimerizationHumanIn VitroInflammatoryInterdisciplinary StudyLabelLigand BindingLigandsLimb structureLipidsMalignant NeoplasmsMethodologyModelingModificationMolecular ConformationMorphogenesisMutationNeoplasm MetastasisNonesterified Fatty AcidsPathogenesisPathogenicityPathologicPathway interactionsPeroxidasesPhosphorylationPhysiologicalPlayProcessPropertyProteinsProteomicsROR1 geneReceptor Protein-Tyrosine KinasesRecyclingResolutionRobinow syndromeRoleSerineSignal PathwaySignal TransductionSignal Transduction PathwayStructureSystemTestingTherapeuticTimeTransmembrane DomainWNT5A proteinWorkascorbatebeta cateninembryo tissueexperimental studyextracellularhuman diseaseimprovednovelpalmitoleic acidprogramsreceptorreconstitutionrecruittherapeutic developmenttranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
The Wnt5a-Ror signaling pathway is essential for embryonic tissue morphogenesis. Disruption of Wnt5a-Ror
signaling results in birth defects such as Robinow syndrome and Brachydactyly Type B, and is frequently
implicated in cancer metastasis and inflammatory disorders. The Wnt5a protein is palmitoleoylated at a
conserved serine, a unique feature shared by all the Wnt ligands, which require the GPCR-like protein Wntless
to transport their lipid-modified mature forms from the endoplasmic reticulum to the plasma membrane for
secretion. In contrast to the canonical Wnts whose mechanisms are relatively well characterized, Wnt5a signals
noncanonically through the ROR family of receptor tyrosine kinases (ROR1/2), which is independent of the
transcriptional factor β-catenin. Despite its physiological and pathological importance, the mechanisms of Wnt5a-
Ror signaling remain poorly understood. The major unanswered questions include how Wnt5a is secreted, how
Wnt5a activates RORs and how active RORs transduce Wnt5a signals to the cytoplasm. In preliminary work, we
determined a Cryo-EM structure of Wnt5a in complex with Wntless that reveals an unanticipated feature of Wnt5a
with important implications for its non-canonical function. We showed that purified extracellular domain (ECD) of
ROR2 promotes Wnt5a secretion, together with the recent crystal structure of Drosophila ROR2 ECD bound with
palmitoleic acid, suggesting that ROR2 directly recognizes the Wnt5a lipid. In addition, we developed a
peroxidase APEX2-catalyzed proximity labeling approach, and by quantitative multiplexed proteomics, we
demonstrated that for the first time, the recruitment of the downstream effector protein Dishevelled (DVL) to the
ROR receptors is exclusively dependent on Wnt5a stimulation. Based on these results, we propose to combine
biochemistry, structural, cell biology and proteomic studies to accomplish the following aims: A) To characterize
how Wntless transports Wnt5a, and how Wntless is recycled after Wnt5a secretion; B) To determine how Wnt5a
binds and activates the ROR receptors; and C) To elucidate how active ROR receptors trigger the downstream
cytoplasmic signaling events. These studies will have high impacts for the following reasons: 1) They will
advance our mechanistic understanding of Wnt5a-Ror signaling; 2) They will help explain the pathogenesis of
human diseases caused by abnormal Wnt5a-Ror signaling; 3) They will facilitate the therapeutic discoveries by
providing novel targets and strategies to treat Wnt5a-associated cancers; and 4) The APEX2-catalyzed proximity
labeling and proteomic approach that we developed will have broad applications to study signal transduction
pathways beyond Wnt5a-Ror signaling.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pengxiang Huang其他文献
Pengxiang Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Structural biochemistry studies on MAP kinase allosteric binding sites
MAP 激酶变构结合位点的结构生物化学研究
- 批准号:
8454542 - 财政年份:2011
- 资助金额:
$ 44.12万 - 项目类别:
Structural biochemistry studies on MAP kinase allosteric binding sites
MAP 激酶变构结合位点的结构生物化学研究
- 批准号:
8099975 - 财政年份:2011
- 资助金额:
$ 44.12万 - 项目类别:
Structural biochemistry studies on MAP kinase allosteric binding sites
MAP 激酶变构结合位点的结构生物化学研究
- 批准号:
8286268 - 财政年份:2011
- 资助金额:
$ 44.12万 - 项目类别:
BIOCHEMISTRY OF LEUKEMIA VIRUS CORE-BINDING FACTOR
白血病病毒核心结合因子的生物化学
- 批准号:
2099053 - 财政年份:1993
- 资助金额:
$ 44.12万 - 项目类别:
BIOCHEMISTRY OF LEUKEMIA VIRUS CORE-BINDING FACTOR
白血病病毒核心结合因子的生物化学
- 批准号:
3202487 - 财政年份:1993
- 资助金额:
$ 44.12万 - 项目类别:
Biochemistry of Leukemia Virus Core Binding Factor
白血病病毒核心结合因子的生物化学
- 批准号:
7161315 - 财政年份:1993
- 资助金额:
$ 44.12万 - 项目类别:
BIOCHEMISTRY OF LEUKEMIA VIRUS CORE-BINDING FACTOR
白血病病毒核心结合因子的生物化学
- 批准号:
2099054 - 财政年份:1993
- 资助金额:
$ 44.12万 - 项目类别:
Biochemistry of Leukemia Virus Core Binding Factor
白血病病毒核心结合因子的生物化学
- 批准号:
6829155 - 财政年份:1993
- 资助金额:
$ 44.12万 - 项目类别:
BIOCHEMISTRY OF LEUKEMIA VIRUS CORE BINDING FACTOR
白血病病毒核心结合因子的生物化学
- 批准号:
6475801 - 财政年份:1993
- 资助金额:
$ 44.12万 - 项目类别:
Biochemistry of Leukemia Virus Core Binding Factor
白血病病毒核心结合因子的生物化学
- 批准号:
8644851 - 财政年份:1993
- 资助金额:
$ 44.12万 - 项目类别: